There has been considerable public interest in the potential role of measles/MMR vaccines in relation to their alleged association with Crohn's disease and juvenile autism. Part of this interest stems from the original findings of studies published by the Royal Free IBD study group predicting a possible association between measles or measles-based vaccines with Crohn's disease and ulcerative colitis. 1, 2 Since the inception of the measles-Crohn's hypothesis in 1993, there have been a series of studies published in the areas of IBD epidemiology, case control studies, serology and molecular diagnosis with relation to measles virus being a possible etiological agent. [3] [4] [5] [6] [7] [8] [9] [10] Although there is a lack of agreement between the findings of the Royal Free IBD group and those published by others, the bulk of the published data do not support any causal association between measles, measles/MMR vaccination and IBD. The first report that predicted an association between measles vaccination and IBD was that of Thompson et al, 2 which examined a cohort of vaccinated children enrolled in the study co-ordinated by the Medical Research Council to examine the efficacy of the live measles virus vaccine. The vaccinated cohort of the MRC study was compared with the unvaccinated cohort of the National Child Development Study comprising of children born in Great Britain during one week in 1958. It was predicted that compared to the control group the vaccinated cohort had a 3-fold increased risk of Crohn's disease and a 2.5-fold increased risk of ulcerative colitis. It is understood that unparalleled study cohorts were examined and compared in that study.
Over the past few years we have conducted several experimental studies using a measles virus-specific RT-PCR based system to test the hypothesis originally proposed by the Royal Free IBD study group. The group had originally reported the presence of measles virus particles in the gut tissues of Crohn's disease and ulcerative colitis patients by a variety of methods including Transmission Electron Microscopy (TEM), immunogold staining and in situ hybridisation. 1 Our results and those published by other groups based on the examination of IBD clinical samples by the RT-PCR method failed to substantiate the findings of the Royal Free group. [4] [5] [6] 8 However, it has been argued by the Royal Free group that failure to detect measles virus genome sequence in IBD tissue is due to poorer diagnostic sensitivities of RT-PCR methods that were applied in different laboratories. 7 This argument is scientifically unfounded on the grounds that published data (Table 1) of RT-PCR results show that methods established and applied in different laboratories were sufficiently sensitive to detect the presence of measles virus genome sequences if they were genuinely present. At this stage, however, the sensitivity limits of assays established in different laboratories can not be directly correlated with each other, as they have been defined either in terms of genome copy numbers or tissue culture infectious dose, eg plaque forming units (p.f.u). In order to resolve the controversy of the diagnostic sensitivities of RT-PCR based assays, or methods similar to them, it is vital that a few preparations of measles virus nucleic acid and virus particles should be evaluated simultaneously under identical experimental conditions in different laboratories. In order to do that, the NIBSC has taken up an initiative to arrange and co-ordinate an international collaborative study in which measles virus-specific samples will be supplied to various independent laboratories, including the laboratory of Professor J O'Leary, Dublin, Ireland, for in-house method(s) evaluation. The Dublin group has established the procedures of TaqMan RT-PCR and in-cell RT-PCR for the detection of measles virus sequences in clinical samples. These procedures have not been applied in any laboratory for the detection of measles virus genome sequences in clinical tissues of IBD and autism cases, therefore, their advantages, in term of assay sensitivity and contamination controls, over the conventional methods remain to be assessed.
None of the conventional RT-PCR based studies conducted have been able to detect the presence of measles virus genome sequences in any clinical specimens of IBD patients despite targeting different parts of the genome for amplification. [4] [5] [6] [7] [8] However, there are two studies, reported recently, that demonstrated the positive identification of measles virus genome sequences in the clinical specimens of IBD and autism cases. 9 The study reported by Kawashima and colleagues has been questioned as it contains several data anomalies and is also inconsistent with the published work that applied a similar diagnostic method. 11 Moreover, measles virus sequences derived from clinical samples by Kawashima and colleagues failed to cluster with the expected genotype groups in the phylogenetic analysis, confirming the lack of authenticity of the sequence data produced and reported. There are clear indications of the occurrence of cross-contamination of samples either with the pre-existing measles virus laboratory strains and/or nucleic acid molecules produced earlier in the laboratory. 9, 11 Almost every laboratory that attempted to amplify measles virus sequences by the RT-PCR method has encountered the problems of cross-contamination of samples with the material that was used as a positive assay control. 6, 7 This can be sorted out by introducing carefully selected positive and negative controls in the assay format so that any false positive or contaminated samples could be clearly distinguished from the pre-existing templates circulating in the laboratory. These principles were ignored by Kawashima and colleagues who do not describe the nature of the positive control used and also do not take into account the fact that they have manipulated both vaccine and wild-type measles virus strains in their laboratory previously. 12 The second study is reported by the Irish group that also demonstrates the presence of measles virus genome sequences in the gut of children with autistic enterocolitis, the syndrome originally described by Wakefield and colleagues. The data reported by the Irish group to the US Senate's congressional committee on April 6, 2000 are yet to be published in assessable details in any scientific journal. It is not known if measles virus templates amplified by TaqMan PCR from the gut biopsies of autism cases had a genetic identity similar to the vaccine strain or to wild-type strain(s).
The current situation has generated considerable media attention raising doubts on the safety of routine childhood vaccination against measles. The publicity given to this has led to a decline in the vaccination coverage in many parts of UK. There is an urgent need to conduct more research on the issue of post-immunisation safety of measles/MMR vaccine particularly with relation to the growing incidences of juvenile autism.
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